Object. The authors conducted an analysis of prognostic factors for patient
survival and local control of brain metastases after gamma knife radiosurg
ery.
Methods. In the survival analysis, 53 consecutive patients with 121 lesions
treated in the last 2 years were examined. Common primary sites were lung
(26 patients), kidney (seven), breast (three), and colon (three). Patient a
ge ranged from 28 to 75 years (median 58 years) and the female/male ratio w
as 1:0.9. The median tumor volume was 2.1 cm(3) (range 0.02-45.5cm(3)) and
the average prescription dose was 15.4 Gy to the 50% isodose. The median fo
llow up was 12 months (range 1-23 months) and the median survival was 46 we
eks.
Six-month and 1-year survival rates were 63% and 39%, respectively. Karnofs
ky Performance Scale score, tumor volume, and presence of extracranial dise
ase were statistically significant prognostic factors (p < 0.05)for surviva
l in multivariate analysis. Number of lesions, patient age, and adjuvant wh
ole-brain radiation therapy were not statistically significant. Ninety-one
of 121 lesions with follow-up images were included in the local control ana
lysis. The 1-year actuarial local control rate was 48%. In multivariate ana
lysis smaller volume was associated with better control (p = 0.0043), and,
control period of renal cell carcinoma was shorter than that of the other t
umor types (p = 0.0070).
Conclusions. Karnofsky Performance Scale score, tumor volume, controlled pr
imary cancer, and absence of extracranial metastases were associated with l
onger survival in the present study. For local control, tumor volume was a
statistically significant factor.